Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase

doi:10.1084/jem.174.4.821

This Article

	Full Text (PDF, 617K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Mizutani, H.
	Articles by Kupper, T. S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Mizutani, H.
	Articles by Kupper, T. S.


Social Bookmarking

	What's this?

ARTICLES

Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase

H Mizutani, N Schechter, G Lazarus, RA Black and TS Kupper
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Secretory granules of human dermal mast cells contain a chymotrypsin- like serine proteinase called chymase. In this study, we demonstrate that the inactive cytokine, 31 kD interleukin 1 beta (IL-1 beta), can be converted rapidly to an 18 kD biologically active species by human mast cell chymase. The product formed is three amino acids longer at the amino terminus than the mature IL-1 beta produced by peripheral blood mononuclear cells and has comparable biological activity. Because chymase is a secretory granule constituent, it is likely to be released into the surrounding tissue when mast cells degranulate. It is also known that non-bone marrow derived cells resident in skin (keratinocytes, fibroblasts) produce but do not process 31 kD IL-1 beta. In this context, chymase may be a potent activator of locally produced 31 kD IL-1 beta. Mast cells lie in close apposition to blood vessels in dermis; therefore, chymase mediated conversion of 31 kD IL-1 beta might be expected to have a critical role in the initiation of the inflammatory response in skin.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Hailey, K. L., Li, S., Andersen, M. D., Roy, M., Woods, V. L. Jr, Jennings, P. A. (2009). Pro-interleukin (IL)-1{beta} Shares a Core Region of Stability as Compared with Mature IL-1{beta} While Maintaining a Distinctly Different Configurational Landscape: A COMPARATIVE HYDROGEN/DEUTERIUM EXCHANGE MASS SPECTROMETRY STUDY. J. Biol. Chem. 284: 26137-26148 [Abstract] [Full Text]
Andersson, M. K., Enoksson, M., Gallwitz, M., Hellman, L. (2009). The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile. Int Immunol 21: 95-104 [Abstract] [Full Text]
Guillabert, A., Wittamer, V., Bondue, B., Godot, V., Imbault, V., Parmentier, M., Communi, D. (2008). Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J. Leukoc. Biol. 84: 1530-1538 [Abstract] [Full Text]
Ghavami, S., Hashemi, M., de Serres, F. J., Bajestani, S. N., Mehrabifar, H., Leonardi, A. (2007). Trypsin Inhibitory Capacity in Vernal Keratoconjunctivitis. IOVS 48: 264-269 [Abstract] [Full Text]
Omoto, Y., Tokime, K., Yamanaka, K., Habe, K., Morioka, T., Kurokawa, I., Tsutsui, H., Yamanishi, K., Nakanishi, K., Mizutani, H. (2006). Human Mast Cell Chymase Cleaves Pro-IL-18 and Generates a Novel and Biologically Active IL-18 Fragment. J. Immunol. 177: 8315-8319 [Abstract] [Full Text]
Chamberlain, J., Evans, D., King, A., Dewberry, R., Dower, S., Crossman, D., Francis, S. (2006). Interleukin-1{beta} and Signaling of Interleukin-1 in Vascular Wall and Circulating Cells Modulates the Extent of Neointima Formation in Mice. Am. J. Pathol. 168: 1396-1403 [Abstract] [Full Text]
Zhao, W., Oskeritzian, C. A., Pozez, A. L., Schwartz, L. B. (2005). Cytokine Production by Skin-Derived Mast Cells: Endogenous Proteases Are Responsible for Degradation of Cytokines. J. Immunol. 175: 2635-2642 [Abstract] [Full Text]
Sakamoto, N., Mukae, H., Fujii, T., Ishii, H., Yoshioka, S., Kakugawa, T., Sugiyama, K., Mizuta, Y., Kadota, J.-i., Nakazato, M., Kohno, S. (2005). Differential effects of {alpha}- and {beta}-defensin on cytokine production by cultured human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L508-L513 [Abstract] [Full Text]
Carter, C. R. D., Whitmore, K. M., Thorpe, R. (2004). The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation. J. Leukoc. Biol. 75: 515-522 [Abstract] [Full Text]
Doggrell, S. A, Wanstall, J. C (2004). Vascular chymase: pathophysiological role and therapeutic potential of inhibition. Cardiovasc Res 61: 653-662 [Abstract] [Full Text]
Raymond, W. W., Ruggles, S. W., Craik, C. S., Caughey, G. H. (2003). Albumin Is a Substrate of Human Chymase: PREDICTION BY COMBINATORIAL PEPTIDE SCREENING AND DEVELOPMENT OF A SELECTIVE INHIBITOR BASED ON THE ALBUMIN CLEAVAGE SITE. J. Biol. Chem. 278: 34517-34524 [Abstract] [Full Text]
Singh, M., Saini, H. K. (2003). Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury. J CARDIOVASC PHARMACOL THER 8: 135-148 [Abstract]
Uehara, Y., Urata, H., Ideishi, M., Arakawa, K., Saku, K. (2002). Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. Cardiovasc Res 55: 870-876 [Abstract] [Full Text]
Lazaar, A. L., Plotnick, M. I., Kucich, U., Crichton, I., Lotfi, S., Das, S. K. P., Kane, S., Rosenbloom, J., Panettieri, R. A. Jr., Schechter, N. M., Pure, E. (2002). Mast Cell Chymase Modifies Cell-Matrix Interactions and Inhibits Mitogen-Induced Proliferation of Human Airway Smooth Muscle Cells. J. Immunol. 169: 1014-1020 [Abstract] [Full Text]
Hara, M., Ono, K., Hwang, M.-W., Iwasaki, A., Okada, M., Nakatani, K., Sasayama, S., Matsumori, A. (2002). Evidence for a Role of Mast Cells in the Evolution to Congestive Heart Failure. JEM 195: 375-381 [Abstract] [Full Text]
Bank, U., Ansorge, S. (2001). More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 69: 197-206 [Abstract] [Full Text]
Arakawa, K., Urata, H. (2000). Hypothesis Regarding the Pathophysiological Role of Alternative Pathways of Angiotensin II Formation in Atherosclerosis. Hypertension 36: 638-641 [Abstract] [Full Text]
Yamanaka, K.-i., Tanaka, M., Tsutsui, H., Kupper, T. S., Asahi, K., Okamura, H., Nakanishi, K., Suzuki, M., Kayagaki, N., Black, R. A., Miller, D. K., Nakashima, K., Shimizu, M., Mizutani, H. (2000). Skin-Specific Caspase-1-Transgenic Mice Show Cutaneous Apoptosis and Pre-Endotoxin Shock Condition with a High Serum Level of IL-18. J. Immunol. 165: 997-1003 [Abstract] [Full Text]
Gardella, S., Andrei, C., Costigliolo, S., Olcese, L., Zocchi, M. R., Rubartelli, A. (2000). Secretion of bioactive interleukin-1beta by dendritic cells is modulated by interaction with antigen specific T cells. Blood 95: 3809-3815 [Abstract] [Full Text]
Muramatsu, M., Katada, J., Hayashi, I., Majima, M. (2000). Chymase as a Proangiogenic Factor. A POSSIBLE INVOLVEMENT OF CHYMASE-ANGIOTENSIN-DEPENDENT PATHWAY IN THE HAMSTER SPONGE ANGIOGENESIS MODEL. J. Biol. Chem. 275: 5545-5552 [Abstract] [Full Text]
Uehara, Y., Urata, H., Sasaguri, M., Ideishi, M., Sakata, N., Tashiro, T., Kimura, M., Arakawa, K. (2000). Increased Chymase Activity in Internal Thoracic Artery of Patients With Hypercholesterolemia. Hypertension 35: 55-60 [Abstract] [Full Text]
Yao, J.-H., Ye, S.-M., Burgess, W., Zachary, J. F., Kelley, K. W., Johnson, R. W. (1999). Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 277: R1435-R1443 [Abstract] [Full Text]
Ihara, M., Urata, H., Kinoshita, A., Suzumiya, J., Sasaguri, M., Kikuchi, M., Ideishi, M., Arakawa, K. (1999). Increased Chymase-Dependent Angiotensin II Formation in Human Atherosclerotic Aorta. Hypertension 33: 1399-1405 [Abstract] [Full Text]
Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., Cheronis, J. (1999). Converting enzyme-independent release of tumor necrosis factor alpha �and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. USA 96: 6261-6266 [Abstract] [Full Text]
Beausejour, A., Grenier, D., Goulet, J.-P., Deslauriers, N. (1998). Proteolytic Activation of the Interleukin-1beta Precursor by Candida albicans. Infect. Immun. 66: 676-681 [Abstract] [Full Text]
Schick, C., Kamachi, Y., Bartuski, A. J., Cataltepe, S., Schechter, N. M., Pemberton, P. A., Silverman, G. A. (1997). Squamous Cell Carcinoma Antigen 2Is a Novel Serpin That Inhibits the Chymotrypsin-like Proteinases Cathepsin G and Mast Cell Chymase. J. Biol. Chem. 272: 1849-1855 [Abstract] [Full Text]
Tchougounova, E., Forsberg, E., Angelborg, G., Kjellen, L., Pejler, G. (2001). Altered Processing of Fibronectin in Mice Lacking Heparin. A ROLE FOR HEPARIN-DEPENDENT MAST CELL CHYMASE IN FIBRONECTIN DEGRADATION. J. Biol. Chem. 276: 3772-3777 [Abstract] [Full Text]